HALISTER: Merck CEO Says Drug-Price Debate Doesn’t Account for R&D Risks

Merck CEO Says Drug-Price Debate Doesn’t Account for R&D Risks

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
MRK US (Merck & Co Inc)

People
Barack Obama (United States of America)
Kenneth Frazier (Merck & Co Inc)
Hillary Clinton (United States of America)
Ian Read (Pfizer Inc)
Leonard Saltz (Memorial Sloan-Kettering Center)

Topics
CEO Interviews
Corporate Inversions

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283